Astrana Health (ASTH) Stock Forecast, Price Target & Predictions


OverviewRevenueOwnershipFinancialsChartTranscripts

ASTH Stock Forecast


Astrana Health stock forecast is as follows: an average price target of $61.67 (represents a 50.67% upside from ASTH’s last price of $40.93) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

ASTH Price Target


The average price target for Astrana Health (ASTH) is $61.67 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $70.00 to $48.00. This represents a potential 50.67% upside from ASTH's last price of $40.93.

ASTH Analyst Ratings


Buy

According to 8 Wall Street analysts, Astrana Health's rating consensus is 'Buy'. The analyst rating breakdown for ASTH stock is 0 'Strong Buy' (0.00%), 5 'Buy' (62.50%), 3 'Hold' (37.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Astrana Health Price Target by Analyst


DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 03, 2024David LarsenBTIG$70.00$57.8720.96%71.02%
Aug 15, 2024Michael HaRobert W. Baird$67.00$46.5843.84%63.69%
Jun 27, 2024Chris O'CullStifel Nicolaus$48.00$40.5018.52%17.27%
Row per page
Go to

The latest Astrana Health stock forecast, released on Oct 03, 2024 by David Larsen from BTIG, set a price target of $70.00, which represents a 20.96% increase from the stock price at the time of the forecast ($57.87), and a 71.02% increase from ASTH last price ($40.93).

Astrana Health Price Target by Period


1M3M12M
# Anlaysts-13
Avg Price Target-$70.00$61.67
Last Closing Price$40.93$40.93$40.93
Upside/Downside-100.00%71.02%50.67%

In the current month, the average price target of Astrana Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Astrana Health's last price of $40.93. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades


DateCompanyPrevious RatingNew RatingRating Change
Oct 14, 2024Cowen & Co.-BuyInitialise
Oct 10, 2024KeyBanc-Sector WeightInitialise
Oct 03, 2024BTIGBuyBuyHold
Jul 11, 2024GuggenheimNeutralNeutralHold
Jul 11, 2024WedbushOutperformOutperformHold
Jul 11, 2024Leerink PartnersOutperformOutperformHold
Jul 11, 2024Morgan Stanley-Equal-WeightDowngrade
Jul 11, 2024Piper SandlerOverweightOverweightHold
Row per page
Go to

Astrana Health's last stock rating was published by Cowen & Co. on Oct 14, 2024. The company Initialise its ASTH rating from "null" to "Buy".

Astrana Health Financial Forecast


Astrana Health Revenue Forecast

Revenue
Avg Forecast
High Forecast
Low Forecast
# Analysts
Surprise %

Astrana Health's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. ASTH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Astrana Health EBITDA Forecast

# Analysts
EBITDA
Avg Forecast
High Forecast
Low Forecast
Surprise %

undefined analysts predict ASTH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Astrana Health's previous annual EBITDA (undefined) of $NaN.

Astrana Health Net Income Forecast

# Analysts
Net Income
Avg Forecast
High Forecast
Low Forecast
Surprise %

Astrana Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. ASTH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Astrana Health SG&A Forecast

# Analysts
SG&A
Avg Forecast
High Forecast
Low Forecast
Surprise %

Astrana Health's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to ASTH last annual SG&A of $NaN (undefined).

Astrana Health EPS Forecast

# Analysts
EPS
Avg Forecast
High Forecast
Low Forecast
Surprise %

According to undefined Wall Street analysts, Astrana Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to ASTH previous annual EPS of $NaN (undefined).

ASTH Forecast FAQ


Is Astrana Health a good buy?

Yes, according to 8 Wall Street analysts, Astrana Health (ASTH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 62.50% of ASTH's total ratings.

What is ASTH's price target?

Astrana Health (ASTH) average price target is $61.67 with a range of $48 to $70, implying a 50.67% from its last price of $40.93. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Astrana Health stock go up soon?

According to Wall Street analysts' prediction for ASTH stock, the company can go up by 50.67% (from the last price of $40.93 to the average price target of $61.67), up by 71.02% based on the highest stock price target, and up by 17.27% based on the lowest stock price target.

Can Astrana Health stock reach $60?

ASTH's average twelve months analyst stock price target of $61.67 supports the claim that Astrana Health can reach $60 in the near future.